aluates Reports

$ 0.0

Automative

Hyper Immune Globulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-8S8242

Global and Japan Hyper Immune Globulin Market Insights Forecast to 2027

BUY CHAPTERS

Hyper Immune Globulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8S8242

Report

October 2024

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Behring

Grifols S A

Biotest

Kedrion S p A

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai Raas

Sichuan Yuanda Shuyang

ADMA Biologics

Hyper Immune Globulin - Market Size

The global market for Hyper Immune Globulin was estimated to be worth US$ 1867 million in 2023 and is forecast to a readjusted size of US$ 2839.8 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Hyper Immune Globulin - Market

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hyper Immune Globulin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hyper Immune Globulin by region & country, by Type, and by Application.

The Hyper Immune Globulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyper Immune Globulin.

Market Segmentation

Scope of Hyper Immune Globulin - Market Report

Report Metric	Details
Report Name	Hyper Immune Globulin - Market
Forecasted market size in 2030	US$ 2839.8 million
CAGR	6.2%
Forecasted years	2024 - 2030
Segment by Type:	Hepatitis B Immunoglobulins Rabies Immunoglobulins Tetanus Immunoglobulins Rho(D) Immunoglobulins Others
Segment by Application	Government Institutions Private Sector Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hyper Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hyper Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hyper Immune Globulin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Hyper Immune Globulin - Market size in 2030?

Ans: The Hyper Immune Globulin - Market size in 2030 will be US$ 2839.8 million.

Who are the main players in the Hyper Immune Globulin - Market report?

Ans: The main players in the Hyper Immune Globulin - Market are CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics

What are the Application segmentation covered in the Hyper Immune Globulin - Market report?

Ans: The Applications covered in the Hyper Immune Globulin - Market report are Government Institutions, Private Sector, Others

What are the Type segmentation covered in the Hyper Immune Globulin - Market report?

Ans: The Types covered in the Hyper Immune Globulin - Market report are Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins, Others

Recommended Reports

Immunoglobulin Markets

Hyperimmune & Animal

Vaccines & Therapeutics

1 Market Overview

1.1 Hyper Immune Globulin Product Introduction

1.2 Global Hyper Immune Globulin Market Size Forecast

1.2.1 Global Hyper Immune Globulin Sales Value (2019-2030)

1.2.2 Global Hyper Immune Globulin Sales Volume (2019-2030)

1.2.3 Global Hyper Immune Globulin Sales Price (2019-2030)

1.3 Hyper Immune Globulin Market Trends & Drivers

1.3.1 Hyper Immune Globulin Industry Trends

1.3.2 Hyper Immune Globulin Market Drivers & Opportunity

1.3.3 Hyper Immune Globulin Market Challenges

1.3.4 Hyper Immune Globulin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hyper Immune Globulin Players Revenue Ranking (2023)

2.2 Global Hyper Immune Globulin Revenue by Company (2019-2024)

2.3 Global Hyper Immune Globulin Players Sales Volume Ranking (2023)

2.4 Global Hyper Immune Globulin Sales Volume by Company Players (2019-2024)

2.5 Global Hyper Immune Globulin Average Price by Company (2019-2024)

2.6 Key Manufacturers Hyper Immune Globulin Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Hyper Immune Globulin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Hyper Immune Globulin

2.9 Hyper Immune Globulin Market Competitive Analysis

2.9.1 Hyper Immune Globulin Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Hyper Immune Globulin Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyper Immune Globulin as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Hepatitis B Immunoglobulins

3.1.2 Rabies Immunoglobulins

3.1.3 Tetanus Immunoglobulins

3.1.4 Rho(D) Immunoglobulins

3.1.5 Others

3.2 Global Hyper Immune Globulin Sales Value by Type

3.2.1 Global Hyper Immune Globulin Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Hyper Immune Globulin Sales Value, by Type (2019-2030)

3.2.3 Global Hyper Immune Globulin Sales Value, by Type (%) (2019-2030)

3.3 Global Hyper Immune Globulin Sales Volume by Type

3.3.1 Global Hyper Immune Globulin Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Hyper Immune Globulin Sales Volume, by Type (2019-2030)

3.3.3 Global Hyper Immune Globulin Sales Volume, by Type (%) (2019-2030)

3.4 Global Hyper Immune Globulin Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Government Institutions

4.1.2 Private Sector

4.1.3 Others

4.2 Global Hyper Immune Globulin Sales Value by Application

4.2.1 Global Hyper Immune Globulin Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Hyper Immune Globulin Sales Value, by Application (2019-2030)

4.2.3 Global Hyper Immune Globulin Sales Value, by Application (%) (2019-2030)

4.3 Global Hyper Immune Globulin Sales Volume by Application

4.3.1 Global Hyper Immune Globulin Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Hyper Immune Globulin Sales Volume, by Application (2019-2030)

4.3.3 Global Hyper Immune Globulin Sales Volume, by Application (%) (2019-2030)

4.4 Global Hyper Immune Globulin Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Hyper Immune Globulin Sales Value by Region

5.1.1 Global Hyper Immune Globulin Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Hyper Immune Globulin Sales Value by Region (2019-2024)

5.1.3 Global Hyper Immune Globulin Sales Value by Region (2025-2030)

5.1.4 Global Hyper Immune Globulin Sales Value by Region (%), (2019-2030)

5.2 Global Hyper Immune Globulin Sales Volume by Region

5.2.1 Global Hyper Immune Globulin Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Hyper Immune Globulin Sales Volume by Region (2019-2024)

5.2.3 Global Hyper Immune Globulin Sales Volume by Region (2025-2030)

5.2.4 Global Hyper Immune Globulin Sales Volume by Region (%), (2019-2030)

5.3 Global Hyper Immune Globulin Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Hyper Immune Globulin Sales Value, 2019-2030

5.4.2 North America Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Hyper Immune Globulin Sales Value, 2019-2030

5.5.2 Europe Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Hyper Immune Globulin Sales Value, 2019-2030

5.6.2 Asia Pacific Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Hyper Immune Globulin Sales Value, 2019-2030

5.7.2 South America Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Hyper Immune Globulin Sales Value, 2019-2030

5.8.2 Middle East & Africa Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hyper Immune Globulin Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Hyper Immune Globulin Sales Value

6.2.1 Key Countries/Regions Hyper Immune Globulin Sales Value, 2019-2030

6.2.2 Key Countries/Regions Hyper Immune Globulin Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Hyper Immune Globulin Sales Value, 2019-2030

6.3.2 United States Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Hyper Immune Globulin Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Hyper Immune Globulin Sales Value, 2019-2030

6.4.2 Europe Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Hyper Immune Globulin Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Hyper Immune Globulin Sales Value, 2019-2030

6.5.2 China Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

6.5.3 China Hyper Immune Globulin Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Hyper Immune Globulin Sales Value, 2019-2030

6.6.2 Japan Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Hyper Immune Globulin Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Hyper Immune Globulin Sales Value, 2019-2030

6.7.2 South Korea Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Hyper Immune Globulin Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Hyper Immune Globulin Sales Value, 2019-2030

6.8.2 Southeast Asia Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Hyper Immune Globulin Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Hyper Immune Globulin Sales Value, 2019-2030

6.9.2 India Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

6.9.3 India Hyper Immune Globulin Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CSL Behring

7.1.1 CSL Behring Company Information

7.1.2 CSL Behring Introduction and Business Overview

7.1.3 CSL Behring Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.1.4 CSL Behring Hyper Immune Globulin Product Offerings

7.1.5 CSL Behring Recent Development

7.2 Grifols

7.2.1 Grifols Company Information

7.2.2 Grifols Introduction and Business Overview

7.2.3 Grifols Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Grifols Hyper Immune Globulin Product Offerings

7.2.5 Grifols Recent Development

7.3 Biotest

7.3.1 Biotest Company Information

7.3.2 Biotest Introduction and Business Overview

7.3.3 Biotest Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Biotest Hyper Immune Globulin Product Offerings

7.3.5 Biotest Recent Development

7.4 Kedrion

7.4.1 Kedrion Company Information

7.4.2 Kedrion Introduction and Business Overview

7.4.3 Kedrion Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Kedrion Hyper Immune Globulin Product Offerings

7.4.5 Kedrion Recent Development

7.5 CBPO

7.5.1 CBPO Company Information

7.5.2 CBPO Introduction and Business Overview

7.5.3 CBPO Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.5.4 CBPO Hyper Immune Globulin Product Offerings

7.5.5 CBPO Recent Development

7.6 Emergent (Cangene)

7.6.1 Emergent (Cangene) Company Information

7.6.2 Emergent (Cangene) Introduction and Business Overview

7.6.3 Emergent (Cangene) Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Emergent (Cangene) Hyper Immune Globulin Product Offerings

7.6.5 Emergent (Cangene) Recent Development

7.7 Kamada

7.7.1 Kamada Company Information

7.7.2 Kamada Introduction and Business Overview

7.7.3 Kamada Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Kamada Hyper Immune Globulin Product Offerings

7.7.5 Kamada Recent Development

7.8 CNBG

7.8.1 CNBG Company Information

7.8.2 CNBG Introduction and Business Overview

7.8.3 CNBG Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.8.4 CNBG Hyper Immune Globulin Product Offerings

7.8.5 CNBG Recent Development

7.9 Hualan Bio

7.9.1 Hualan Bio Company Information

7.9.2 Hualan Bio Introduction and Business Overview

7.9.3 Hualan Bio Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Hualan Bio Hyper Immune Globulin Product Offerings

7.9.5 Hualan Bio Recent Development

7.10 Shanghai RAAS

7.10.1 Shanghai RAAS Company Information

7.10.2 Shanghai RAAS Introduction and Business Overview

7.10.3 Shanghai RAAS Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Shanghai RAAS Hyper Immune Globulin Product Offerings

7.10.5 Shanghai RAAS Recent Development

7.11 Sichuan Yuanda Shuyang

7.11.1 Sichuan Yuanda Shuyang Company Information

7.11.2 Sichuan Yuanda Shuyang Introduction and Business Overview

7.11.3 Sichuan Yuanda Shuyang Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Sichuan Yuanda Shuyang Hyper Immune Globulin Product Offerings

7.11.5 Sichuan Yuanda Shuyang Recent Development

7.12 ADMA Biologics

7.12.1 ADMA Biologics Company Information

7.12.2 ADMA Biologics Introduction and Business Overview

7.12.3 ADMA Biologics Hyper Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

7.12.4 ADMA Biologics Hyper Immune Globulin Product Offerings

7.12.5 ADMA Biologics Recent Development

8 Industry Chain Analysis

8.1 Hyper Immune Globulin Industrial Chain

8.2 Hyper Immune Globulin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hyper Immune Globulin Sales Model

8.5.2 Sales Channel

8.5.3 Hyper Immune Globulin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

CSL Behring

Grifols S A

Biotest

Kedrion S p A

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai Raas

Sichuan Yuanda Shuyang

ADMA Biologics

List of Tables

Table 1. Hyper Immune Globulin Market Trends

Table 2. Hyper Immune Globulin Market Drivers & Opportunity

Table 3. Hyper Immune Globulin Market Challenges

Table 4. Hyper Immune Globulin Market Restraints

Table 5. Global Hyper Immune Globulin Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Hyper Immune Globulin Revenue Market Share by Company (2019-2024)

Table 7. Global Hyper Immune Globulin Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Hyper Immune Globulin Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Hyper Immune Globulin Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Hyper Immune Globulin Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Hyper Immune Globulin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Hyper Immune Globulin

Table 13. Global Hyper Immune Globulin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyper Immune Globulin as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hyper Immune Globulin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Hyper Immune Globulin Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Hyper Immune Globulin Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Hyper Immune Globulin Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Hyper Immune Globulin Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Hyper Immune Globulin Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Hyper Immune Globulin Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Hyper Immune Globulin Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Hyper Immune Globulin Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Hyper Immune Globulin Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Hyper Immune Globulin Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Hyper Immune Globulin Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Hyper Immune Globulin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Hyper Immune Globulin Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Hyper Immune Globulin Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Hyper Immune Globulin Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Hyper Immune Globulin Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Hyper Immune Globulin Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Hyper Immune Globulin Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Hyper Immune Globulin Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Hyper Immune Globulin Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Hyper Immune Globulin Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Hyper Immune Globulin Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Hyper Immune Globulin Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Hyper Immune Globulin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Hyper Immune Globulin Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Hyper Immune Globulin Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Hyper Immune Globulin Sales Value by Region (2019-2024) & (%)

Table 44. Global Hyper Immune Globulin Sales Value by Region (2025-2030) & (%)

Table 45. Global Hyper Immune Globulin Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Hyper Immune Globulin Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Hyper Immune Globulin Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Hyper Immune Globulin Sales Volume by Region (2019-2024) & (%)

Table 49. Global Hyper Immune Globulin Sales Volume by Region (2025-2030) & (%)

Table 50. Global Hyper Immune Globulin Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Hyper Immune Globulin Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Hyper Immune Globulin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Hyper Immune Globulin Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Hyper Immune Globulin Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Hyper Immune Globulin Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Hyper Immune Globulin Sales Volume, (2025-2030) & (K Units)

Table 57. CSL Behring Company Information

Table 58. CSL Behring Introduction and Business Overview

Table 59. CSL Behring Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. CSL Behring Hyper Immune Globulin Product Offerings

Table 61. CSL Behring Recent Development

Table 62. Grifols Company Information

Table 63. Grifols Introduction and Business Overview

Table 64. Grifols Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Grifols Hyper Immune Globulin Product Offerings

Table 66. Grifols Recent Development

Table 67. Biotest Company Information

Table 68. Biotest Introduction and Business Overview

Table 69. Biotest Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Biotest Hyper Immune Globulin Product Offerings

Table 71. Biotest Recent Development

Table 72. Kedrion Company Information

Table 73. Kedrion Introduction and Business Overview

Table 74. Kedrion Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Kedrion Hyper Immune Globulin Product Offerings

Table 76. Kedrion Recent Development

Table 77. CBPO Company Information

Table 78. CBPO Introduction and Business Overview

Table 79. CBPO Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. CBPO Hyper Immune Globulin Product Offerings

Table 81. CBPO Recent Development

Table 82. Emergent (Cangene) Company Information

Table 83. Emergent (Cangene) Introduction and Business Overview

Table 84. Emergent (Cangene) Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Emergent (Cangene) Hyper Immune Globulin Product Offerings

Table 86. Emergent (Cangene) Recent Development

Table 87. Kamada Company Information

Table 88. Kamada Introduction and Business Overview

Table 89. Kamada Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Kamada Hyper Immune Globulin Product Offerings

Table 91. Kamada Recent Development

Table 92. CNBG Company Information

Table 93. CNBG Introduction and Business Overview

Table 94. CNBG Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. CNBG Hyper Immune Globulin Product Offerings

Table 96. CNBG Recent Development

Table 97. Hualan Bio Company Information

Table 98. Hualan Bio Introduction and Business Overview

Table 99. Hualan Bio Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Hualan Bio Hyper Immune Globulin Product Offerings

Table 101. Hualan Bio Recent Development

Table 102. Shanghai RAAS Company Information

Table 103. Shanghai RAAS Introduction and Business Overview

Table 104. Shanghai RAAS Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Shanghai RAAS Hyper Immune Globulin Product Offerings

Table 106. Shanghai RAAS Recent Development

Table 107. Sichuan Yuanda Shuyang Company Information

Table 108. Sichuan Yuanda Shuyang Introduction and Business Overview

Table 109. Sichuan Yuanda Shuyang Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Sichuan Yuanda Shuyang Hyper Immune Globulin Product Offerings

Table 111. Sichuan Yuanda Shuyang Recent Development

Table 112. ADMA Biologics Company Information

Table 113. ADMA Biologics Introduction and Business Overview

Table 114. ADMA Biologics Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. ADMA Biologics Hyper Immune Globulin Product Offerings

Table 116. ADMA Biologics Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Hyper Immune Globulin Downstream Customers

Table 120. Hyper Immune Globulin Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Hyper Immune Globulin Product Picture

Figure 2. Global Hyper Immune Globulin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Hyper Immune Globulin Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Hyper Immune Globulin Sales Volume (2019-2030) & (K Units)

Figure 5. Global Hyper Immune Globulin Sales Price (2019-2030) & (US$/Unit)

Figure 6. Hyper Immune Globulin Report Years Considered

Figure 7. Global Hyper Immune Globulin Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Hyper Immune Globulin Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hyper Immune Globulin Revenue in 2023

Figure 10. Hyper Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Hepatitis B Immunoglobulins Picture

Figure 12. Rabies Immunoglobulins Picture

Figure 13. Tetanus Immunoglobulins Picture

Figure 14. Rho(D) Immunoglobulins Picture

Figure 15. Others Picture

Figure 16. Global Hyper Immune Globulin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Hyper Immune Globulin Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Hyper Immune Globulin Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Hyper Immune Globulin Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Hyper Immune Globulin Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Government Institutions

Figure 22. Product Picture of Private Sector

Figure 23. Product Picture of Others

Figure 24. Global Hyper Immune Globulin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Hyper Immune Globulin Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Hyper Immune Globulin Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Hyper Immune Globulin Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Hyper Immune Globulin Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Hyper Immune Globulin Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Hyper Immune Globulin Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Hyper Immune Globulin Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Hyper Immune Globulin Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Hyper Immune Globulin Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Hyper Immune Globulin Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Hyper Immune Globulin Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Hyper Immune Globulin Sales Volume (%), (2019-2030)

Figure 41. United States Hyper Immune Globulin Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Hyper Immune Globulin Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Hyper Immune Globulin Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Hyper Immune Globulin Sales Value by Application (%), 2023 VS 2030

Figure 47. China Hyper Immune Globulin Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

Figure 49. China Hyper Immune Globulin Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Hyper Immune Globulin Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Hyper Immune Globulin Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Hyper Immune Globulin Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Hyper Immune Globulin Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Hyper Immune Globulin Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Hyper Immune Globulin Sales Value by Application (%), 2023 VS 2030

Figure 59. India Hyper Immune Globulin Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Hyper Immune Globulin Sales Value by Type (%), 2023 VS 2030

Figure 61. India Hyper Immune Globulin Sales Value by Application (%), 2023 VS 2030

Figure 62. Hyper Immune Globulin Industrial Chain

Figure 63. Hyper Immune Globulin Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hyperimmune Globulin Product Market Research Report 2024

Global Human Hyperimmune Globulins Market Research Report 2024

Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hyperimmune Globulin Injection Market Research Report 2024

Global Intravenous Immunoglobulin IVIg Market Research Report 2025

Global Intravenous Immune Globulin Therapies Market Research Report 2024

Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Rabies Immune Globulin HRIG Market Research Report 2024

Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal derived Immune Globulin Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prophylactic Gamma Globulin Market Research Report 2024

Immune Globulins Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Immumoglobulin PH4 for Intravenous Injection Market Insights Forecast to 2030

Human Varicella Zoster Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions